Otsuka (OTCMKTS:OTSKY) Shares Gap Up – Here’s Why

Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKYGet Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $35.35, but opened at $36.71. Otsuka shares last traded at $36.2545, with a volume of 1,631 shares changing hands.

Otsuka Stock Up 2.8%

The stock has a fifty day moving average of $36.86 and a 200 day moving average of $35.23. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.21 and a quick ratio of 1.65. The firm has a market capitalization of $39.04 billion, a P/E ratio of 14.59, a price-to-earnings-growth ratio of 2.54 and a beta of 0.02.

Otsuka (OTCMKTS:OTSKYGet Free Report) last announced its earnings results on Friday, July 31st. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.19. The firm had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka had a return on equity of 12.86% and a net margin of 15.50%.Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. On average, research analysts anticipate that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current fiscal year.

About Otsuka

(Get Free Report)

Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products group whose businesses span pharmaceuticals, nutraceuticals and consumer health products, as well as related medical and chemical activities. The company operates primarily through subsidiaries including Otsuka Pharmaceutical Co, Ltd. and serves customers in Japan and international markets.

Otsuka’s pharmaceutical operations focus on prescription medicines in areas such as psychiatry, oncology, nephrology, cardiovascular disease and several other therapeutic fields.

Featured Stories

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.